Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a leading biotechnology company based in Uttar Pradesh India. The company is a Govt. of India Undertaking and has its OPV plant in state of Uttar Pradesh, India. The company currently manufactures and produces a range of pharmaceuticals products such as Oral Polio Vaccines (OPV Vaccine), Zinc Tablet & Diarrhea Management Kit, Ready to Use Therapeutic Food (RUTF) etc.

BIBCOL is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science & Technology, Government of India. BIBCOL was established as a Public Sector Unit in 1989, with the aim to achieve self sufficiency for the nation with respect to production and supply of high quality polio vaccine.

BIBCOL’s main objective is to save the lives of millions of children from various diseases. Since its inception, it has contributed significantly to the eradication of Poliomyelitis in the country by supplying billons of doses of oral polio vaccine. BIBCOL is the pioneer in the field of polio vaccines, capturing 60% of total market share in India. Based on the performance of the company and its world class WHO-cGMP certified infrastructure, highly skilled manpower and constant support from DBT, Government of India,

 

MISSION

BIBCOL's principal mission is to save millions of children from various diseases. Since its inception, BIBCOL has contributed significantly to the eradication of poliomyelitis in the country by supplying billions of doses of oral polio vaccine to the Government of India in the National Immunization Program.

BIBCOL produces dispersible zinc tablets for treatment of diarrhea among young children. Recently BIBCOL has introduced RUTF for treatment of malnourishment among severely acute malnourished children. BIBCOL also plans to manufacture various bio tech products, which are helpful in the treatment of various health disorders and deficiencies of the mankind like albumin and immunoglobulin.

 

Goal

  • BIBCOL is expected to continue the formulation of bOPV till there is demand from Government.
  • Contribution for total elimination of polio from the country through continuous support to National Immunization Program.
  • Expansion/Diversification of product portfolio by introduction of Plasma Derived Medicines (PDMs).
  • Manufacture of various nutraceuticals and biologicals for treatment of health deficiencies and disorders.